// App-Quantinova.ai

2251 : High Sensitivity C-Reactive Protein, Disease Activity and Cardiovascular Risk Factors in Systemic Lupus Erythematosus

Researchers

Presenter

  • Chi Chiu Mok

Principal Investigators

  • Daniel Birmingham

  • Ling Yin Ho

  • Brad H. Rovin

Medical Centers

  • Medicine, Tuen Mun Hospital, Hong Kong, Hong Kong, Medicine, Ohio State University Medical Center, Columbus, OH, Division of Nephrology, Ohio State University Medical Center, Columbus, OH

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Lupus

Biomarkers

  • Nucleoside diphosphate kinase A

  • C reactive protein

  • High sensitivity C-reactive protein

  • Albumin/creatinine

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim